Form 4 for CNTX Context Therapeutics Inc.
Accepted 2021-10-25 00:00:00 ET · period of report 2021-10-22 · accession 0001179110-21-009609 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2021-10-25 | 2021-10-22 | CNTX | Lehr Martin A. | CEO, Dir | C - Cnv Deriv | — | +797.2K | 849.9K | +1,513% | — |
| D | 2021-10-25 | 2021-10-22 | CNTX | Lehr Martin A. | CEO, Dir | P - Purchase | $5.00 | +10.0K | 99.6K | +11% | +$50.0K |
| DI | 2021-10-25 | 2021-10-22 | CNTX | Lehr Martin A. | CEO, Dir | O - OTM Ex | $7.14 | +52.7K | 52.7K | New | +$376.1K |
| DMI | 2021-10-25 | 2021-10-22 | CNTX | Lehr Martin A. | CEO, Dir | C - Cnv Deriv | — | -797.2K | 0 | -100% | — |
| DI | 2021-10-25 | 2021-10-22 | CNTX | Lehr Martin A. | CEO, Dir | O - OTM Ex | $0.00 | +52.7K | 0 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-22 | C | A | 210,722 | — | 263,402 | I Martin Lehr 2000 Trust | — | — | (F1) Each share of Series A Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering. |
| 2 | Common | Common Stock | 2021-10-22 | P | A | 10,000 | $5.00 | 99,583 | D Martin Lehr 2000 Trust | — | — | |
| 3 | Common | Common Stock | 2021-10-22 | O | A | 52,680 | $7.14 | 52,680 | I Martin Lehr 2000 Trust | — | — | |
| 4 | Common | Common Stock | 2021-10-22 | C | A | 586,476 | — | 849,878 | I | — | — | (F3) Each share of Series Seed Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering. |
| 5 | Derivative | Series A Preferred Stock | 2021-10-22 | C | D | 210,722 | — | 0 | I Martin Lehr 2000 Trust | — · — to — | 210,722 Common Stock | (F1) Each share of Series A Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering. (F2) Fully vested. |
| 6 | Derivative | Series Seed Preferred Stock | 2021-10-22 | C | D | 586,476 | — | 0 | I Martin Lehr 2000 Trust | — · — to — | 586,476 Common Stock | (F3) Each share of Series Seed Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering. (F2) Fully vested. |
| 7 | Derivative | Warrant (right to buy) | 2021-10-22 | O | A | 52,680 | $0.00 | 0 | I Martin Lehr 2000 Trust | $7.14 · 2020-12-20 to 2030-12-20 | 52,680 Common Stock |